Compare SNY & BN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNY | BN |
|---|---|---|
| Founded | 1994 | 1997 |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 104.6B |
| IPO Year | N/A | N/A |
| Metric | SNY | BN |
|---|---|---|
| Price | $48.43 | $47.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $61.50 | $42.41 |
| AVG Volume (30 Days) | 2.4M | ★ 3.6M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.32% | 0.49% |
| EPS Growth | ★ 105.93 | 7.66 |
| EPS | ★ 8.67 | 0.35 |
| Revenue | $53,890,648,839.00 | ★ $76,933,000,000.00 |
| Revenue This Year | $1.73 | N/A |
| Revenue Next Year | $6.49 | $68.39 |
| P/E Ratio | ★ $5.55 | $132.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $44.62 | $29.07 |
| 52 Week High | $60.12 | $49.57 |
| Indicator | SNY | BN |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 53.50 |
| Support Level | $47.17 | $45.66 |
| Resistance Level | $48.95 | $49.57 |
| Average True Range (ATR) | 0.54 | 0.99 |
| MACD | 0.06 | 0.32 |
| Stochastic Oscillator | 75.77 | 57.23 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has seven operating segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Corporate Activities. It invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. The company generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, Colombia, Germany, Other Europe, Other Asia, and other countries.